Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ICML 2017 | Exploring and consolidating the CLL world

Ulrich Jäger, MD from the Medical University of Vienna, Vienna, Austria tells us about his personal highlights regarding chronic lymphocytic leukemia (CLL) from the International Conference on Malignant Lymphoma (ICML) 2017 in Lugano, Switzerland. He is particularly excited about new drug combinations, specifically venetoclax and obinutuzumab which have shown very positive results. However he believes that the medical community are still exploring the CLL world.